| Application no. and date | 19726391.6 (espacenet) (Federated) (European Patent Register), 20190523 | | Patent/reg. no. and date | DK/EP 3796896, 20251231 | | Publication date | 20210331 | | Priority no. and date | GB 201808462, 20180523 | | EP pub. no. and date |
EP 3796896 20210331 | | Effective date | | | Applicant/owner | Klaria Pharma Holding AB, Virdings Allé 2
754 50 Uppsala, SE | | Applicant ref. no. | V504161DK00 | | Inventor | BOYER, Scott, Virdings Allé 2
754 50 Uppsala, SE,
HÜBINETTE, Fredrik, Virdings Allé 2
754 50 Uppsala, SE,
INGEMARSSON, Leif, Virdings Allé 2
754 50 Uppsala, SE,
CAI, Shengzhen, Virdings Allé 2
754 50 Uppsala, SE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/135 (2006.01) , A61K 31/137 (2006.01) , A61K 47/36 (2006.01) , A61K 9/70 (2006.01) , A61P 37/00 (2006.01) | | Title | Farmaceutisk adrenalinformulering | | Int. application no. | EP2019063376 | | Int. publication no. | WO2019224323 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
